PyXy.AI · Project

AI Stethoscope That Lets Anyone Do Expert-Level Lung and Heart Checks at Home

healthPilotedTRL 7

Imagine a smart stethoscope that listens to your lungs and heart, takes your temperature, checks your blood oxygen, and then uses AI to tell you if something is wrong — all without needing a doctor in the room. That's what PyXy does. It was originally built to help monitor COVID-19 patients at home so hospitals wouldn't get overwhelmed, but it works for anyone with chronic heart or lung conditions. Think of it as giving every home the diagnostic power of an experienced physician's ear.

By the numbers

200

Advanced prototype units produced

EUR 4,863,275

EU contribution for development

Consortium partners

Countries involved (DE, IL, NO)

86%

Industry partners in consortium

22 months

Planned time to market introduction

The business problem

What needed solving

Hospitals and care facilities are overwhelmed by chronic cardiopulmonary patients who need frequent check-ups, while there aren't enough skilled medical staff to go around. Every unnecessary hospitalization costs thousands, and informal caregivers at home have no way to perform reliable diagnostic assessments. The gap between what patients need and what the healthcare system can deliver keeps growing.

The solution

What was built

A handheld AI-powered auscultation device (PyXy) that measures lung sounds, heart sounds, infrasound, body temperature, blood oxygen, heart rate, and respiratory cycle — all analyzed by artificial intelligence. The project produced 200 advanced prototype units and developed the manufacturing process for high-volume production.

Audience

Who needs this

Home healthcare and elderly care facility operators struggling with staff shortagesMedical device distributors looking for telehealth productsHealth insurers seeking to reduce chronic patient hospitalization costsTelemedicine platform providers wanting to add diagnostic hardwareNursing home chains managing cardiopulmonary patients remotely

Business applications

Who can put this to work

Home healthcare and elderly care services

mid-size

Target: Home care providers and elderly care facility operators

If you are a home care provider dealing with rising hospitalization costs and a shortage of skilled medical staff — this project developed a handheld AI-powered diagnostic device (200 advanced prototype units produced) that lets caregivers perform expert-level lung and heart assessments without specialist training. The 7-partner consortium across 3 countries specifically included healthcare service providers to validate real-world acceptance.

Medical device distribution

any

Target: Medical device distributors and e-health solution resellers

If you are a medical device distributor looking for the next telehealth product to add to your portfolio — this EUR 4,863,275 Innovation Action produced a market-ready AI auscultation device that combines sound analysis, body temperature, blood oxygen, heart rate, and respiratory cycle monitoring in one unit. The consortium included Riester, an established medical device player, signaling serious manufacturing and distribution readiness.

Health insurance and managed care

enterprise

Target: Health insurers and managed care organizations

If you are a health insurer looking to reduce emergency hospitalization costs for chronic cardiopulmonary patients — this project built a device that enables remote patient monitoring by lesser-skilled individuals or even informal caregivers at home. With 86% industry partners in the consortium and 200 advanced prototypes manufactured, the technology is designed to cut hospital admissions and shift care to lower-cost settings.

Frequently asked

Quick answers

What would a PyXy device cost to acquire or license?

The project data does not disclose unit pricing. However, with EUR 4,863,275 in EU funding, 200 advanced prototype units produced, and an established medical device manufacturer (Riester) in the consortium, the device was engineered for high-volume manufacturing. Contact the coordinator for commercial pricing and licensing terms.

Can this scale to industrial-level production?

Yes — the project explicitly aimed to take PyXy to high-volume manufacturing level. The consortium includes Riester, an established medical device company, and the deliverables confirm 200 advanced prototype units were produced. The manufacturing pathway appears well-defined.

What is the IP and licensing situation?

The coordinator is Sanolla Ltd (Israel), the developer of the PyXy device. IP is likely held by Sanolla with possible consortium agreements. Licensing or distribution inquiries should be directed to Sanolla. Based on available project data, no open-source licensing was indicated.

Does this meet medical device regulations in Europe?

The project was funded under Horizon 2020 with healthcare service providers in Germany, Israel, and Norway validating the device. As an Innovation Action targeting market introduction within 22 months, regulatory compliance (CE marking) was part of the commercialization plan. Current certification status should be confirmed with the coordinator.

How quickly could we deploy this in our care facilities?

The project ran from December 2020 to January 2023 and produced 200 advanced prototype units. The consortium included 4 healthcare service providers (Natali, BeneVit, Helgeland, PhilonMed) who tested market acceptance. Deployment timelines depend on current production status — contact the coordinator for availability.

Does it integrate with existing telehealth and EHR systems?

The project was designed as a telehealth-ready system, meaning remote monitoring was a core feature. The consortium included Medsensio, specialists in AI classification, suggesting cloud-based data processing capabilities. Specific EHR integration details should be confirmed with the development team.

Consortium

Who built it

This is a heavily industry-driven consortium — 6 out of 7 partners are from industry (86%), with zero universities involved, which is unusual for EU projects and signals a strong commercial intent. The coordinator Sanolla Ltd is an Israeli SME that developed the core PyXy device, partnered with Medsensio for AI classification and Riester, an established German medical device manufacturer capable of scaling production. Four healthcare service providers (Natali, BeneVit, Helgeland, PhilonMed) across Germany, Israel, and Norway served as validation partners, ensuring the product was tested against real market needs. With 3 SMEs in the mix and EUR 4,863,275 in funding, this consortium was built to commercialize, not just research.

How to reach the team

Sanolla Ltd (Israel) — visit pyxy.ai or search for Sanolla Ltd leadership on LinkedIn for direct contact

Order a report on this consortium

Next steps

Talk to the team behind this work.

Want an introduction to the PyXy.AI team? SciTransfer can connect you with the right person at Sanolla and help you evaluate whether this technology fits your care setting or product portfolio.

Order a report on this topic More in Health & Biomedical